Author:
Schneider B.,Martin S.,Scherbaum W. A.,Heinemann L.,Lodwig V.,Kolb H.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference10 articles.
1. Hoffmann F, Andersohn F (2010) Immortal time bias and survival in patients who self-monitor blood glucose in the retrolective study: self-monitoring of blood glucose and outcome in patients with type 2 diabetes (ROSSO). Diabetologia. doi: 10.1007/s00125-010-1909-3
2. Martin S, Schneider B, Heinemann L et al (2006) Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49:271–278
3. Suissa S (2008) Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 167:492–499
4. Schneider B, Martin S, Heinemann L, Lodwig V, Kolb H (2007) Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes/results of a longitudinal cohort study (ROSSO 5). Arzneimittelforschung 57:762–769
5. Kolb H, Schneider S, Heinemann L et al (2008) Type 2 diabetes phenotype and progression is significantly different if diagnosed before vs after 56 years of age. J Diabetes Sci Technol 2:82–90